Suchergebnisse - "SCHOLLER JOHN"

PubPharm (169)

1

Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors

enthalten in: bioRxiv.org | 2024

von Xiao, Z. | Todd, L. | Huang, L. | +14

2

IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Tilsed, C. | Sadiq, B. | Papp, T. | +13

3

Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Roselle, C. | Horikawa, I. | Chen, L. | +12

CommentIn: Proc Natl Acad Sci U S A. 2024 Mar 19;121(12):e2402533121. - PMID 38466858

4

Uso del dominio de señalización de CD2 en receptores de antígenos quiméricos de segunda generación

enthalten in: Europäisches Patentamt | 2024

von JUNE CARL H | SCHOLLER JOHN | POSEY AVERY

5

ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cells

enthalten in: Scientific reports | 2024

von Mai, D. | Boyce, T. | Mehta, A. | +4

6

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor

enthalten in: Europäisches Patentamt | 2024

von BROGDON JENNIFER | JOHNSON LAURA ALEXANDRA | JUNE CARL H | +4

7

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor

enthalten in: Europäisches Patentamt | 2024

von BROGDON JENNIFER | JOHNSON LAURA ALEXANDRA | JUNE CARL H | +4

8

USE OF THE CD2 SIGNALING DOMAIN IN SECOND-GENERATION CHIMERIC ANTIGEN RECEPTORS

enthalten in: Europäisches Patentamt | 2024

von JUNE CARL H | SCHOLLER JOHN | POSEY AVERY D

9

USE OF THE CD2 SIGNALING DOMAIN IN SECOND-GENERATION CHIMERIC ANTIGEN RECEPTORS

enthalten in: Europäisches Patentamt | 2024

von JUNE CARL H | SCHOLLER JOHN | POSEY AVERY D

10

TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR

enthalten in: Europäisches Patentamt | 2024

von BROGDON JENNIFER | JUNE CARL H | LOEW ANDREAS | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]